Inhibition of tumor growth, lymphangiogenesis, and metastasis by iron chelators, deferoxamine and deferasirox, in breast cancers

被引：0
|
作者：
Kang, Han Na [1 ]
Kang, Myoung Hee [1 ]
Km, Jung Lim [1 ]
Kim, Jun Suk [2 ]
Choi, Chul Won [2 ]
Seo, Jea Hong [2 ]
Yoo, Young A. [3 ]
机构：
[1] Korea Univ, Coll Med, Grad Sch Med, Seoul 136705, South Korea
[2] Korea Univ, Dept Internal Med, Div Oncol Hematol, Seoul, South Korea
[3] Korea Univ, Coll Med, Brain Korea Program Biomed Sci 21, Seoul 136705, South Korea
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4465
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4465
引用
收藏
页数：1
相关论文
共 50 条
  • [31] INHIBITION OF GROWTH OF THE LYMPHOCYTE LINES BY DEFEROXAMINE UNDER VARIOUS IRON-SUPPLY CONDITIONS
    KOVAR, J
    SELIGMAN, P
    GELFAND, EW
    FOLIA BIOLOGICA, 1993, 39 (01) : 29 - 39
  • [32] Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
    Anne Saaristo
    Terhi Karpanen
    Kari Alitalo
    Oncogene, 2000, 19 : 6122 - 6129
  • [33] Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
    Saaristo, A
    Karpanen, T
    Alitalo, K
    ONCOGENE, 2000, 19 (53) : 6122 - 6129
  • [34] Inhibition of breast cancer growth and metastasis by a biomimetic peptide
    Esak Lee
    Seung Jae Lee
    Jacob E. Koskimaki
    Zheyi Han
    Niranjan B. Pandey
    Aleksander S. Popel
    Scientific Reports, 4
  • [35] Inhibition of breast cancer growth and metastasis by a biomimetic peptide
    Lee, Esak
    Lee, Seung Jae
    Koskimaki, Jacob E.
    Han, Zheyi
    Pandey, Niranjan B.
    Popel, Aleksander S.
    SCIENTIFIC REPORTS, 2014, 4
  • [36] ROLE OF RIBONUCLEOTIDE REDUCTASE IN INHIBITION OF MAMMALIAN-CELL GROWTH BY POTENT IRON CHELATORS
    NYHOLM, S
    MANN, GJ
    JOHANSSON, AG
    BERGERON, RJ
    GRASLUND, A
    THELANDER, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (35) : 26200 - 26205
  • [37] Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial
    Walter, Patrick B.
    Macklin, Eric A.
    Porter, John
    Evans, Patricia
    Kwiatkowski, Janet L.
    Neufeld, Ellis J.
    Coates, Thomas
    Giardina, Patricia J.
    Vichinsky, Elliott
    Olivieri, Nancy
    Alberti, Daniele
    Holland, Jaymes
    Harmatz, Paul
    Neufeld, Ellis
    Cunningham, Melody
    Braunstein, Jennifer
    Cohen, Alan R.
    Manno, Catherine S.
    Hillman, Debra
    Martin, Marie
    Singer, Sylvia
    Walter, Patrick
    Sweeters, Nancy
    Pang, Eun-Ha
    Foote, Dru
    Nurse, Thalassemia
    Warr, Gladys
    Lui, Annie
    Weihing, Robert
    Wymbs, Kerry
    Merson, Laura
    Muraca, Giulia
    Stamplecoski, Melissa
    Cummins, Michelle
    Grady, Robert W.
    Kleinert, Dorothy
    Mait, Jeffrey E.
    Nathan, David
    Peterson, Charles
    Wright, Libby
    McKinlay, Sonja
    Macklin, Eric
    McCarthy, Ellen
    HAEMATOLOGICA, 2008, 93 (06) : 817 - 825
  • [38] Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple-Negative Breast Cancer
    Cao, Yi
    Ge, Xiaojiao
    Zhu, Xueli
    Han, Yingying
    Wang, Pin
    Akakuru, Ozioma Udochukwu
    Wu, Aiguo
    Li, Juan
    ADVANCED SCIENCE, 2023, 10 (21)
  • [39] Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
    Running, Alice
    Greenwood, Mark
    Hildreth, Laura
    Schmidt, Jade
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [40] Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics
    Zhang, Xueqing
    Huang, Yamei
    Song, Heliang
    Canup, Brandon S. B.
    Gou, Shuangquan
    She, Zhigang
    Dai, Fangyin
    Ke, Bowen
    Xiao, Bo
    JOURNAL OF CONTROLLED RELEASE, 2020, 328 : 454 - 469
12345